TherapeuticsMD (TXMD)

• Market cap: $14.5M
• 1 day: -2.50%
• 5 days: -3.31%
• 1 month: -23.03%
• 3 months: 58.82%
• 6 months: -4.10%
• Year to date: -25.48%
• 1 year: -40.91%
• 5 years: -98.21%
• 10 years: -99.71%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Employees: 1

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

600% more call options, than puts

Call options by funds: $14K | Put options by funds: $2K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 40 [Q4 2024] → 41 (+1) [Q1 2025]

2% more capital invested

Capital invested by funds: $3.03M [Q4 2024] → $3.09M (+$58.1K) [Q1 2025]

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

1.7% less ownership

Funds ownership: 30.61% [Q4 2024] → 28.9% (-1.7%) [Q1 2025]